CLARK WYATT: Open Payments
NPI 1215448246 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 96 payments from 19 companies in 2025. Trend: 2023 $1,942 · 2024 $1,189 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $364 |
| Grifols USA, LLC | 18 | $361 |
| CSL Behring | 8 | $249 |
| Regeneron Healthcare Solutions, Inc. | 6 | $204 |
| GlaxoSmithKline, LLC. | 16 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $157 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $86 |
| BioCryst US Sales Co., LLC | 2 | $65 |
| Amgen Inc. | 3 | $53 |
| Genentech USA, Inc. | 2 | $51 |
Products named: Prolastin-C Liquid, Hizentra, DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, XOLAIR, AIRSUPRA, CUVITRU.
Industry payments across ID — which companies pay providers there.
